The effect of erectile dysfunction (ED) on sexual planning behaviors and outcomes in men taking phosphodiesterase type 5 inhibitors (PDE5Is) is not well studied.
To assess sexual habits, behaviors, and treatment-related outcomes of PDE5I-treated men with ED.